Loading...
Response evaluation after primary systemic therapy of Her2 positive breast cancer – an observational cross-sectional study
AIM: To evaluate (I) trastuzumab-containing primary systemic therapy (PST) in human epidermal growth factor receptor 2 (Her2) overexpressing breast carcinomas; (II) compare the patients who achieved and those who did not achieve pathological complete remission (pCR), and (III) analyze the accuracy o...
Na minha lista:
| Udgivet i: | Croat Med J |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Croatian Medical Schools
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4410165/ https://ncbi.nlm.nih.gov/pubmed/25891872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3325/cmj.2015.56.128 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|